What laboratory tests should be ordered for a patient with chronic diarrhea and dyspepsia when celiac disease is being considered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Chronic Diarrhea and Dyspepsia When Considering Celiac Disease

Order IgA tissue transglutaminase (tTG-IgA) plus total IgA level as your first-line serologic screen for celiac disease. 1

Initial Screening Panel

  • IgA tissue transglutaminase (tTG-IgA) is the preferred first-line test with 90.7% sensitivity and 87.4% specificity in adults at 15 U/mL threshold 1
  • Total IgA level must be measured simultaneously because IgA deficiency occurs in 1-3% of celiac patients and causes falsely negative IgA-based tests 1
  • Complete blood count (CBC) to screen for iron deficiency anemia, which is present in 2-6% of celiac disease patients 2
  • C-reactive protein (CRP) or fecal calprotectin/lactoferrin to screen for inflammatory bowel disease, though the AGA suggests against using ESR or CRP specifically for IBD screening (conditional recommendation) 1, 2
  • Basic metabolic panel to assess for electrolyte abnormalities from chronic diarrhea 2

Confirmatory Testing When tTG-IgA Is Positive

  • IgA endomysial antibody (EMA) should be added when tTG-IgA is elevated, providing superior specificity of 99.6% in adults 1
  • When tTG-IgA exceeds 10 times the upper limit of normal and EMA is positive in a second blood sample, the positive predictive value for celiac disease approaches 100% 1

Testing for IgA-Deficient Patients

  • If total IgA is low or absent, switch to IgG deamidated gliadin peptide (DGP-IgG), which demonstrates 93.6% sensitivity and 99.4% specificity in adults 1
  • IgG tTG has limited utility (40.6-84.6% sensitivity, 78.0-89.0% specificity) and should not be used as a primary screen when IgA is normal 1, 3

Additional Testing for Chronic Diarrhea

  • Stool test for Giardia (strong recommendation, high-quality evidence) because Giardia is a common cause of chronic diarrhea and fatty diarrhea 1
  • Fecal calprotectin or fecal lactoferrin to screen for inflammatory bowel disease (conditional recommendation, low-quality evidence) 1
  • Consider bile acid diarrhea testing (conditional recommendation, low-quality evidence), though tests are limited in North America; an empiric trial of bile acid sequestrants is reasonable when suspected 1

Critical Pre-Test Requirements

  • Patients must consume at least 10g of gluten daily for 6-8 weeks before serologic testing to avoid false-negative results 1
  • Never initiate a gluten-free diet before completing diagnostic workup, as this invalidates both serology and biopsy results 1

Common Pitfalls to Avoid

  • Do not order IgG tTG as a primary screen when total IgA is normal—it generates frequent false-positives with poor specificity 1, 3
  • Do not rely on isolated positive tTG IgG with negative tTG IgA; this pattern has only 3% diagnostic utility for celiac disease 3
  • Do not skip measuring total IgA when ordering tTG-IgA, as IgA deficiency is 10-fold more common in celiac patients (2.6% vs 0.2% general population) 1
  • Do not diagnose celiac disease based on serology alone in adults—duodenal biopsy with at least 6 specimens from the second part of the duodenum remains mandatory for confirmation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.

Journal of pediatric gastroenterology and nutrition, 2017

Related Questions

What is the most appropriate next step for an asymptomatic 18‑month‑old child with normal growth who is a first‑degree relative of a patient with celiac disease?
What is the best course of treatment for a patient with chronic diarrhea, bloating, and mucus in stools, who also has a history of weight loss, acid reflux, nocturnal diarrhea, intermittent rash, eczema, hyperferritinemia, elevated B12, vitamin D deficiency, mildly elevated liver enzymes (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)), increased lactate dehydrogenase (LDH), intestinal yeast, and increased inflammatory markers in stool?
What is the best course of action for a 5-year-old patient with abdominal pain, bloating, loose stools, and poor growth, presenting with an eczematous rash and hyperactive bowel sounds?
What is the most appropriate next step for an 18‑month‑old child with normal growth and a first‑degree relative (older sibling) diagnosed with celiac disease?
In a patient suspected of celiac disease who is on a gluten‑containing diet, what is the preferred initial serologic blood test?
Can a patient with coronary artery disease and elevated liver function tests on atorvastatin be started on rosuvastatin (Crestor) instead?
For bipolar disorder, should I use lamotrigine extended‑release (XR) or immediate‑release (IR) tablets?
What are the possible causes of a low white blood cell (WBC) count?
Can a lidocaine 5% patch be applied to the shoulder and neck?
What is the recommended adult dosing and administration of Levosin (hyoscyamine sulfate) for reducing excessive secretions, and what monitoring is required?
Which pharmacogenetic test should be ordered to evaluate genes influencing lidocaine metabolism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.